NCT06977633View on ClinicalTrials.gov

Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

April 30, 2027

Conditions
Type 1 Diabetes (T1D)
Interventions
BEHAVIORAL

Temporary Insulin Suspension

Participants will suspend insulin delivery from their personal insulin pumps for up to 3 hours. Insulin suspension is temporary and participant-driven under supervision.

DEVICE

Glucose and ketone sensor

The participants wear a prototype continuous glucose-ketone monitoring (CGM-CKM) device using painless hydrogel microneedles for 4 hours.

Trial Locations (1)

94304

Stanford University, Palo Alto

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Mahla Poudineh

OTHER